ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 5676 to 5699 of 99175 messages
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
30/4/2020
12:13
Good progress on trial with 75% on initial tranche already treated
blueblood
30/4/2020
12:12
Gold as we knew
nick9013
30/4/2020
12:11
news hitting the tape gents...what we already knew however
markinvestor
30/4/2020
12:10
*SYNAIRGEN GOT APPROVALS TO EXTEND SARS-COV-2 SG016 TRIAL
markinvestor
30/4/2020
11:57
A real problem we have are tests aren't robust and giving false results. Spoke to friend who works on front line and says he's had a patient with clear C19 symptoms that didn't test positive until 4th swab!
blueblood
30/4/2020
11:54
Home treatment combined with an easy quick test will be the future, especially care homes which can keep a stock on standby. Avacta's test out in June (?) is a saliva, spit on a stick, lateral flow test. Low cost and results in 10 minutes.
pdt
30/4/2020
11:38
I think it is showing some success and the earlier treatment is started the better, hence the home trial. That’s just my layman’s view but if true shows we have a real winner here.
rafboy
30/4/2020
11:36
Synairgen is discussed in the podcast - very brief mention from 36:34

The fund manager also discusses in the podcast how she has invested in Synairgen (SNG:AIM) and other stocks looking to treat coronavirus or help pharma companies to find a vaccine.

makendon
30/4/2020
11:31
Apologies for re-posting - I missed news of the amendment yesterday - This is a significant development in my opinion - The trial must be yielding positive results
hotmark
30/4/2020
11:31
Thanks for posting the info Hotmark.

High expectation of a serious winner here !

westmoreland lad
30/4/2020
11:30
Thursdays are great. I suppose that is why I purchased so many on Monday and Tuesday hoping that my theory of a blue Thursday would happen
vitec
30/4/2020
11:29
Great trading share with extras added each time.
bmnsa
30/4/2020
11:29
I assume it's people buying that were not aware of the amendment.
markinvestor
30/4/2020
11:28
Up again:))
bmnsa
30/4/2020
11:28
It's going so well today we may even see Likya! :-)
dovey21
30/4/2020
11:26
Should see a move back to 60@s on the bid shortly, great reversal
tburns
30/4/2020
11:25
Up she rises.
bmnsa
30/4/2020
11:23
Yes thanks. It has been discussed on this thread since yesterday.
markinvestor
30/4/2020
11:20
Expecting an RNS later today - Good luck to all LTHs
hotmark
30/4/2020
11:17
A significant amendment to the trial was approved yesterday
hotmark
30/4/2020
11:11
@wilkinson_team
·
2h
Professor Tom Wilkinson will be the clinical academic lead for ACCORD, a new collaborative national programme aiming to accelerate drug development processes from years to months to get new #COVID19 treatments into national trials

markinvestor
30/4/2020
11:01
Nobbygnome
29 Apr '20 - 10:51 - 5460 of 5590

AA GILL once compared a steak he ate in the Elephant in London as " tough as old boots" he explained that whilst he felt bad for doing so he couldn't think of anything finer by way of expressive narrative... "Tarts draws" You are forgiven as its certainly apt though Brownian Motion could equally describe some of the random share movements in these volatile markets.

ant15
30/4/2020
11:00
Exactly, but I suspect it's release created a short lived bounce.
gbh2
30/4/2020
11:00
They are hoping for some results around mid June so we should know ourselves before then.
cambradjones
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older

Your Recent History

Delayed Upgrade Clock